# Mycobacterium w in Patients With Severe Sepsis

> **NCT02330432** · PHASE2,PHASE3 · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 202 (actual)

## Conditions studied

- Sepsis

## Interventions

- **BIOLOGICAL:** Mycobacterium w
- **OTHER:** Best standard care

## Key facts

- **NCT ID:** NCT02330432
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2021-02-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330432, "Mycobacterium w in Patients With Severe Sepsis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02330432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*